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Mastocytosis is a rare disease characterized by activating
KIT mutations and clonal expansion of mast cells (MCs)
in tissues, particularly in skin and bone marrow.
Symptoms of mastocytosis always correlate with the extent
of MC infiltration and include urticaria pigmentosa,
anaphylaxis, flushing, headache, diarrhea, osteoporosis and
pruritus. Interleukin 31 (IL-31) is a new recently identified
pruritogenic factor mainly produced by activated T cells,
but also by mast cells. Recently published data indicated
that IL-31 level is increased in adult patients with
mastocytosis.
The aim of our study is to compare the frequency of
-1066 G/A, -2057 G/A and IVS2+12 polymorphisms of
IL-31 gene which upregulate gene transcription in
mastocytosis patients and healthy control groups.
Using ARMS-PCR methods we analyze the polymorph-
isms of IL-31 gene in 240 mastocytosis patients and 110
healthy controls.
We have found that in comparison to the control
mastocytosis patients have more frequently AA genotype
in all three analyzed polymorphisms: -1066 AA: 17,7% vs
8,2%, p=0,02; -2057 AA: 7,5% vs 1,1%, p=0,024, IVS2+12
AA 63,6 vs 40%, p=0,007. The presence of -2057 AA
genotype more than 7x increase the risk of mastocytosis:
OR = 7,38 (0,97-56.09) p = 0,05.
In conclusion, results of our study indicate that
mastocytosis could be associated with IL-31 gene
polymorphisms
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